BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bove K, Lincoln DW, Tsan MF. Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem Biophys Res Commun. 2002;291:1001-1005. [PMID: 11866465 DOI: 10.1006/bbrc.2002.6554] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Martelli A, Omrani M, Zarghooni M, Citi V, Brogi S, Calderone V, Sureda A, Lorzadeh S, da Silva Rosa SC, Grabarek BO, Staszkiewicz R, Los MJ, Nabavi SF, Nabavi SM, Mehrbod P, Klionsky DJ, Ghavami S. New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways. Cancers (Basel) 2022;14. [PMID: 36497321 DOI: 10.3390/cancers14235839] [Reference Citation Analysis]
2 Kumstel S, Schreiber T, Goldstein L, Stenzel J, Lindner T, Joksch M, Zhang X, Wendt EHU, Schönrogge M, Krause B, Vollmar B, Zechner D. Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism. PLoS ONE 2022;17:e0266601. [DOI: 10.1371/journal.pone.0266601] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Adibfar S, Elveny M, Kashikova HS, Mikhailova MV, Farhangnia P, Vakili-Samiani S, Tarokhian H, Jadidi-Niaragh F. The molecular mechanisms and therapeutic potential of EZH2 in breast cancer. Life Sci 2021;286:120047. [PMID: 34653429 DOI: 10.1016/j.lfs.2021.120047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Bonsignore G, Patrone M, Grosso F, Martinotti S, Ranzato E. Cancer Therapy Challenge: It Is Time to Look in the "St. Patrick's Well" of the Nature. Int J Mol Sci 2021;22:10380. [PMID: 34638721 DOI: 10.3390/ijms221910380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hu LF, Lan HR, Li XM, Jin KT. A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities. Oxid Med Cell Longev 2021;2021:2951697. [PMID: 34471463 DOI: 10.1155/2021/2951697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
6 Arabzadeh A, Mortezazadeh T, Aryafar T, Gharepapagh E, Majdaeen M, Farhood B. Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review. Cancer Cell Int 2021;21:391. [PMID: 34289841 DOI: 10.1186/s12935-021-02099-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
7 Wan MLY, Co VA, El-Nezami H. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies. Crit Rev Food Sci Nutr 2021;:1-27. [PMID: 33819127 DOI: 10.1080/10408398.2021.1903382] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
8 AbouAitah K, Lojkowski W. Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy. Pharmaceutics 2021;13:143. [PMID: 33499150 DOI: 10.3390/pharmaceutics13020143] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
9 Patra S, Pradhan B, Nayak R, Behera C, Rout L, Jena M, Efferth T, Bhutia SK. Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics. Semin Cancer Biol 2021;73:310-20. [PMID: 33152486 DOI: 10.1016/j.semcancer.2020.10.010] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 14.0] [Reference Citation Analysis]
10 Wu H, Chen L, Zhu F, Han X, Sun L, Chen K. The Cytotoxicity Effect of Resveratrol: Cell Cycle Arrest and Induced Apoptosis of Breast Cancer 4T1 Cells. Toxins (Basel) 2019;11:E731. [PMID: 31847250 DOI: 10.3390/toxins11120731] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
11 Mousazadeh R, Hesaraki S, Bayat M, Jahandideh A, Hashemi J. Anticancer tendency of aflatoxin B1 in 4T1 breast cancer cell line. Gene Reports 2019;16:100442. [DOI: 10.1016/j.genrep.2019.100442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Hu C, Liu Y, Teng M, Jiao K, Zhen J, Wu M, Li Z. Resveratrol inhibits the proliferation of estrogen receptor-positive breast cancer cells by suppressing EZH2 through the modulation of ERK1/2 signaling. Cell Biol Toxicol 2019;35:445-56. [PMID: 30941654 DOI: 10.1007/s10565-019-09471-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
13 Carafa V, Altucci L, Nebbioso A. Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype. Front Pharmacol 2019;10:38. [PMID: 30761005 DOI: 10.3389/fphar.2019.00038] [Cited by in Crossref: 81] [Cited by in F6Publishing: 87] [Article Influence: 20.3] [Reference Citation Analysis]
14 Liu YH, Xu Y, Liao LD, Chan KC, Thakor NV. A Handheld Real-Time Photoacoustic Imaging System for Animal Neurological Disease Models: From Simulation to Realization. Sensors (Basel) 2018;18:E4081. [PMID: 30469455 DOI: 10.3390/s18114081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
15 Varghese E, Samuel SM, Abotaleb M, Cheema S, Mamtani R, Büsselberg D. The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers. Cancers (Basel) 2018;10:E346. [PMID: 30248941 DOI: 10.3390/cancers10100346] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 11.0] [Reference Citation Analysis]
16 Oh WY, Shahidi F. Antioxidant activity of resveratrol ester derivatives in food and biological model systems. Food Chem 2018;261:267-73. [PMID: 29739593 DOI: 10.1016/j.foodchem.2018.03.085] [Cited by in Crossref: 75] [Cited by in F6Publishing: 83] [Article Influence: 15.0] [Reference Citation Analysis]
17 Boesch M, Onder L, Cheng HW, Novkovic M, Mörbe U, Sopper S, Gastl G, Jochum W, Ruhstaller T, Knauer M, Ludewig B. Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness. Oncoimmunology 2018;7:e1414129. [PMID: 29632733 DOI: 10.1080/2162402X.2017.1414129] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
18 Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS. The Role of Resveratrol in Cancer Therapy. Int J Mol Sci 2017;18:E2589. [PMID: 29194365 DOI: 10.3390/ijms18122589] [Cited by in Crossref: 332] [Cited by in F6Publishing: 355] [Article Influence: 55.3] [Reference Citation Analysis]
19 Ronghe A, Chatterjee A, Singh B, Dandawate P, Abdalla F, Bhat NK, Padhye S, Bhat HK. 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells. Toxicol Appl Pharmacol 2016;301:1-13. [PMID: 26970359 DOI: 10.1016/j.taap.2016.03.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
20 Leipert J, Kässner F, Schuster S, Händel N, Körner A, Kiess W, Garten A. Resveratrol Potentiates Growth Inhibitory Effects of Rapamycin in PTEN-deficient Lipoma Cells by Suppressing p70S6 Kinase Activity. Nutr Cancer 2016;68:342-9. [PMID: 26943752 DOI: 10.1080/01635581.2016.1145244] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sinha D, Sarkar N, Biswas J, Bishayee A. Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms. Semin Cancer Biol 2016;40-41:209-32. [PMID: 26774195 DOI: 10.1016/j.semcancer.2015.11.001] [Cited by in Crossref: 140] [Cited by in F6Publishing: 124] [Article Influence: 20.0] [Reference Citation Analysis]
22 Ge S, Yin T, Xu B, Gao S, Hu M. Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP. Pharm Res 2016;33:590-602. [PMID: 26502886 DOI: 10.1007/s11095-015-1812-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
23 Alayev A, Berger SM, Holz MK. Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation. Ann N Y Acad Sci 2015;1348:116-23. [PMID: 26200935 DOI: 10.1111/nyas.12829] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
24 Park EJ, Pezzuto JM. The pharmacology of resveratrol in animals and humans. Biochim Biophys Acta 2015;1852:1071-113. [PMID: 25652123 DOI: 10.1016/j.bbadis.2015.01.014] [Cited by in Crossref: 190] [Cited by in F6Publishing: 200] [Article Influence: 23.8] [Reference Citation Analysis]
25 Colin DJ, Limagne E, Ragot K, Lizard G, Ghiringhelli F, Solary É, Chauffert B, Latruffe N, Delmas D. The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models. Cell Death Dis 2014;5:e1533. [PMID: 25412311 DOI: 10.1038/cddis.2014.486] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
26 Khan S, Shukla S, Sinha S, Lakra AD, Bora HK, Meeran SM. Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling. Int J Biochem Cell Biol. 2015;58:1-16. [PMID: 25448414 DOI: 10.1016/j.biocel.2014.10.028] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
27 Carter LG, D'Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer 2014;21:R209-25. [PMID: 24500760 DOI: 10.1530/ERC-13-0171] [Cited by in Crossref: 319] [Cited by in F6Publishing: 339] [Article Influence: 35.4] [Reference Citation Analysis]
28 Chen YL, Wang CY, Yang FY, Wang BS, Chen JY, Lin LT, Leu JD, Chiu SJ, Chen FD, Lee YJ, Chen WR. Synergistic effects of glycated chitosan with high-intensity focused ultrasound on suppression of metastases in a syngeneic breast tumor model. Cell Death Dis 2014;5:e1178. [PMID: 24743733 DOI: 10.1038/cddis.2014.159] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
29 Tomé-Carneiro J, Larrosa M, González-Sarrías A, Tomás-Barberán FA, García-Conesa MT, Espín JC. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des. 2013;19:6064-6093. [PMID: 23448440 DOI: 10.2174/13816128113199990407] [Cited by in Crossref: 308] [Cited by in F6Publishing: 324] [Article Influence: 34.2] [Reference Citation Analysis]
30 Visa L, Nadal C, Gascon P. Hedhehog as a New Paradigm in Cancer Treatment. Stem Cells in Cancer: Should We Believe or Not? 2014. [DOI: 10.1007/978-94-017-8754-3_3] [Reference Citation Analysis]
31 Lee-Chang C, Bodogai M, Martin-Montalvo A, Wejksza K, Sanghvi M, Moaddel R, de Cabo R, Biragyn A. Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells. J Immunol 2013;191:4141-51. [PMID: 24043896 DOI: 10.4049/jimmunol.1300606] [Cited by in Crossref: 99] [Cited by in F6Publishing: 107] [Article Influence: 9.9] [Reference Citation Analysis]
32 Pastore S, Lulli D, Maurelli R, Dellambra E, De Luca C, Korkina LG. Resveratrol induces long-lasting IL-8 expression and peculiar EGFR activation/distribution in human keratinocytes: mechanisms and implications for skin administration. PLoS One 2013;8:e59632. [PMID: 23527233 DOI: 10.1371/journal.pone.0059632] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
33 Jeong MH, Yang KM, Choi YJ, Kim SD, Yoo YH, Seo SY, Lee SH, Ryu SR, Lee CM, Suh HS, Jo WS. Resveratrol analog, HS-1793 enhance anti-tumor immunity by reducing the CD4+CD25+ regulatory T cells in FM3A tumor bearing mice. International Immunopharmacology 2012;14:328-33. [DOI: 10.1016/j.intimp.2012.07.018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
34 Jeong SH, Song IS, Kim HK, Lee SR, Song S, Suh H, Yoon YG, Yoo YH, Kim N, Rhee BD, Ko KS, Han J. An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression. Mol Cells 2012;34:357-65. [PMID: 23104437 DOI: 10.1007/s10059-012-0081-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
35 Sun T, Chen Q, Wu L, Yao X, Sun X. Antitumor and antimetastatic activities of grape skin polyphenols in a murine model of breast cancer. Food and Chemical Toxicology 2012;50:3462-7. [DOI: 10.1016/j.fct.2012.07.037] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
36 Lee HS, Ha AW, Kim WK. Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivo. Nutr Res Pract 2012;6:294-300. [PMID: 22977682 DOI: 10.4162/nrp.2012.6.4.294] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
37 Wang J, Jiang YF. Natural compounds as anticancer agents: Experimental evidence. World J Exp Med 2012; 2(3): 45-57 [PMID: 24520533 DOI: 10.5493/wjem.v2.i3.45] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
38 Li Y, Maitah MY, Ahmad A, Kong D, Bao B, Sarkar FH. Targeting the Hedgehog signaling pathway for cancer therapy. Expert Opin Ther Targets. 2012;16:49-66. [PMID: 22243133 DOI: 10.1517/14728222.2011.617367] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
39 Choi YJ, Yang KM, Kim SD, Yoo YH, Lee SW, Seo SY, Suh H, Yee ST, Jeong MH, Jo WS. Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells. Exp Ther Med 2012;3:592-8. [PMID: 22969934 DOI: 10.3892/etm.2012.472] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
40 Park MA, Hwang KA, Choi KC. Diverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property? Lab Anim Res. 2011;27:265-273. [PMID: 22232634 DOI: 10.5625/lar.2011.27.4.265] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
41 Jenkins S, Betancourt AM, Wang J, Lamartiniere CA. Endocrine-active chemicals in mammary cancer causation and prevention. J Steroid Biochem Mol Biol. 2012;129:191-200. [PMID: 21729753 DOI: 10.1016/j.jsbmb.2011.06.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
42 Vang O, Ahmad N, Baile CA, Baur JA, Brown K, Csiszar A, Das DK, Delmas D, Gottfried C, Lin HY, Ma QY, Mukhopadhyay P, Nalini N, Pezzuto JM, Richard T, Shukla Y, Surh YJ, Szekeres T, Szkudelski T, Walle T, Wu JM. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 2011;6:e19881. [PMID: 21698226 DOI: 10.1371/journal.pone.0019881] [Cited by in Crossref: 327] [Cited by in F6Publishing: 339] [Article Influence: 27.3] [Reference Citation Analysis]
43 Chen Q, Liang Z, Sun T, Sun X. Grape skin polyphenols (GSPs) inhibit the migration of mouse mammary carcinoma 4T1 cells in Vitro. Clin Oncol Cancer Res 2011;8. [DOI: 10.1007/s11805-011-0556-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Jäger W, Gruber A, Giessrigl B, Krupitza G, Szekeres T, Sonntag D. Metabolomic Analysis of Resveratrol-Induced Effects in the Human Breast Cancer Cell Lines MCF-7 and MDA-MB-231. OMICS: A Journal of Integrative Biology 2011;15:9-14. [DOI: 10.1089/omi.2010.0114] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
45 Kim EJ, Hong JE, Eom SJ, Lee JY, Park JH. Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. Breast Cancer Res Treat 2011;130:61-71. [PMID: 21170677 DOI: 10.1007/s10549-010-1299-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
46 Baur JA. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 2010;131:261-9. [PMID: 20219519 DOI: 10.1016/j.mad.2010.02.007] [Cited by in Crossref: 155] [Cited by in F6Publishing: 161] [Article Influence: 11.9] [Reference Citation Analysis]
47 Morris BJ. Calorie Restriction Mimetics and Aging. Calorie Restriction, Aging and Longevity 2010. [DOI: 10.1007/978-90-481-8556-6_9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
48 Miksits M, Wlcek K, Svoboda M, Thalhammer T, Ellinger I, Stefanzl G, Falany CN, Szekeres T, Jaeger W. Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism. Cancer Lett 2010;289:237-45. [PMID: 19747768 DOI: 10.1016/j.canlet.2009.08.020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
49 Canistro D, Bonamassa B, Pozzetti L, Sapone A, Abdel-Rahman SZ, Biagi GL, Paolini M. Alteration of xenobiotic metabolizing enzymes by resveratrol in liver and lung of CD1 mice. Food Chem Toxicol. 2009;47:454-461. [PMID: 19101601 DOI: 10.1016/j.fct.2008.11.040] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
50 Pezzuto JM. Resveratrol as an Inhibitor of Carcinogenesis. Pharmaceutical Biology 2008;46:443-573. [DOI: 10.1080/13880200802116610] [Cited by in Crossref: 64] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
51 Punathil T, Tollefsbol TO, Katiyar SK. EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase. Biochem Biophys Res Commun 2008;375:162-7. [PMID: 18692479 DOI: 10.1016/j.bbrc.2008.07.157] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
52 Pezzuto JM. Grapes and Human Health: A Perspective. J Agric Food Chem 2008;56:6777-84. [DOI: 10.1021/jf800898p] [Cited by in Crossref: 135] [Cited by in F6Publishing: 139] [Article Influence: 9.0] [Reference Citation Analysis]
53 Kundu JK, Surh YJ. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008;269:243-261. [PMID: 18550275 DOI: 10.1016/j.canlet.2008.03.057] [Cited by in Crossref: 346] [Cited by in F6Publishing: 360] [Article Influence: 23.1] [Reference Citation Analysis]
54 Murias M, Miksits M, Aust S, Spatzenegger M, Thalhammer T, Szekeres T, Jaeger W. Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer Lett 2008;261:172-82. [PMID: 18082939 DOI: 10.1016/j.canlet.2007.11.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
55 Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007;224:274-283. [PMID: 17306316 DOI: 10.1016/j.taap.2006.12.025] [Cited by in Crossref: 495] [Cited by in F6Publishing: 513] [Article Influence: 30.9] [Reference Citation Analysis]
56 Nichenametla SN, Taruscio TG, Barney DL, Exon JH. A review of the effects and mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr 2006;46:161-83. [PMID: 16431408 DOI: 10.1080/10408390591000541] [Cited by in Crossref: 297] [Cited by in F6Publishing: 221] [Article Influence: 17.5] [Reference Citation Analysis]
57 Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493-506. [PMID: 16732220 DOI: 10.1038/nrd2060] [Cited by in Crossref: 2705] [Cited by in F6Publishing: 2821] [Article Influence: 159.1] [Reference Citation Analysis]
58 Eisnor CR, Gossage RA, Yadav PN. Oxazoline Chemistry. Part 11: Syntheses of natural and synthetic isoflavones, stilbenes and related species via C–C bond formation promoted by a Pd–oxazoline complex. Tetrahedron 2006;62:3395-401. [DOI: 10.1016/j.tet.2006.01.046] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
59 Busquets S, Ametller E, Fuster G, Olivan M, Raab V, Argilés JM, López-Soriano FJ. Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model. Cancer Lett 2007;245:144-8. [PMID: 16466851 DOI: 10.1016/j.canlet.2005.12.035] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
60 Sengottuvelan M, Viswanathan P, Nalini N. Chemopreventive effect of trans -resveratrol - a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 2006;27:1038-46. [DOI: 10.1093/carcin/bgi286] [Cited by in Crossref: 100] [Cited by in F6Publishing: 105] [Article Influence: 5.6] [Reference Citation Analysis]
61 Poussier B, Cordova AC, Becquemin J, Sumpio BE. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. Journal of Vascular Surgery 2005;42:1190-1190.e14. [DOI: 10.1016/j.jvs.2005.08.014] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 3.6] [Reference Citation Analysis]
62 Pezzuto J. Resveratrol as an Inhibitor of Carcinogenesis. Oxidative Stress and Disease 2005. [DOI: 10.1201/9781420026474.ch13] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 Ghidoni R, Signorelli P. Resveratrol as an Antiproliferative Agent for Cancer. Oxidative Stress and Disease 2005. [DOI: 10.1201/9781420026474.ch4] [Reference Citation Analysis]
64 Raul F. Resveratrol as an Antitumor Agent In Vivo. Oxidative Stress and Disease 2005. [DOI: 10.1201/9781420026474.ch14] [Reference Citation Analysis]
65 Le Corre L, Chalabi N, Delort L, Bignon YJ, Bernard-Gallon DJ. Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol Nutr Food Res 2005;49:462-71. [PMID: 15786518 DOI: 10.1002/mnfr.200400094] [Cited by in Crossref: 112] [Cited by in F6Publishing: 116] [Article Influence: 6.2] [Reference Citation Analysis]
66 Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C. Resveratrol and breast cancer risk. Eur J Cancer Prev 2005;14:139-42. [PMID: 15785317 DOI: 10.1097/00008469-200504000-00009] [Cited by in Crossref: 92] [Cited by in F6Publishing: 97] [Article Influence: 5.1] [Reference Citation Analysis]
67 Azios NG, Dharmawardhane SF. Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells. Neoplasia 2005;7:128-40. [PMID: 15802018 DOI: 10.1593/neo.04346] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 4.1] [Reference Citation Analysis]
68 Tyagi A, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 2005;26:1978-87. [PMID: 15975956 DOI: 10.1093/carcin/bgi165] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 6.3] [Reference Citation Analysis]
69 Ulrich S, Wolter F, Stein JM. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol Nutr Food Res 2005;49:452-61. [DOI: 10.1002/mnfr.200400081] [Cited by in Crossref: 106] [Cited by in F6Publishing: 108] [Article Influence: 5.9] [Reference Citation Analysis]
70 Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 2005; 11(2): 280-284 [PMID: 15633232 DOI: 10.3748/wjg.v11.i2.280] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 74] [Article Influence: 3.8] [Reference Citation Analysis]
71 Bode AM, Dong Z. Targeting signal transduction pathways by chemopreventive agents. Mutat Res. 2004;555:33-51. [PMID: 15476850 DOI: 10.1016/j.mrfmmm.2004.05.018] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 4.9] [Reference Citation Analysis]
72 Tangkeangsirisin W, Serrero G. Resveratrol in the Chemoprevention and Chemotherapy of Breast Cancer. Phytopharmaceuticals in Cancer Chemoprevention 2004. [DOI: 10.1201/9780203506707.ch26] [Reference Citation Analysis]
73 Bode A, Dong Z. Beneficial Effects of Resveratrol. Oxidative Stress and Disease 2004. [DOI: 10.1201/9780203021408.ch13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
74 Scarlatti F, Sala G, Somenzi G, Signorelli P, Sacchi N, Ghidoni R. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J. 2003;17:2339-2341. [PMID: 14563682 DOI: 10.1096/fj.03-0292fje] [Cited by in Crossref: 122] [Cited by in F6Publishing: 129] [Article Influence: 6.1] [Reference Citation Analysis]
75 Zhou HB, Yan Y, Sun YN, Zhu JR. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J Gastroenterol 2003; 9(3): 408-411 [PMID: 12632486 DOI: 10.3748/wjg.v9.i3.408] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 55] [Article Influence: 2.6] [Reference Citation Analysis]
76 Brownson DM, Azios NG, Fuqua BK, Dharmawardhane SF, Mabry TJ. Flavonoid Effects Relevant to Cancer. The Journal of Nutrition 2002;132:3482S-9S. [DOI: 10.1093/jn/132.11.3482s] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 3.4] [Reference Citation Analysis]